Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSUVASTATIN\ROSUVASTATIN Cause Condition aggravated? 18 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Condition aggravated have been filed in association with ROSUVASTATIN\ROSUVASTATIN. This represents 3.2% of all adverse event reports for ROSUVASTATIN\ROSUVASTATIN.

18
Reports of Condition aggravated with ROSUVASTATIN\ROSUVASTATIN
3.2%
of all ROSUVASTATIN\ROSUVASTATIN reports
0
Deaths
4
Hospitalizations

How Dangerous Is Condition aggravated From ROSUVASTATIN\ROSUVASTATIN?

Of the 18 reports, 4 (22.2%) required hospitalization.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN\ROSUVASTATIN. However, 18 reports have been filed with the FAERS database.

What Other Side Effects Does ROSUVASTATIN\ROSUVASTATIN Cause?

Dyspnoea (79) Asthma (77) Pneumonia (52) Acute kidney injury (50) Wheezing (50) Myalgia (48) Drug hypersensitivity (46) Fatigue (44) Pain (44) Rhabdomyolysis (43)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which ROSUVASTATIN\ROSUVASTATIN Alternatives Have Lower Condition aggravated Risk?

ROSUVASTATIN\ROSUVASTATIN vs ROTIGOTINE ROSUVASTATIN\ROSUVASTATIN vs ROXADUSTAT ROSUVASTATIN\ROSUVASTATIN vs ROXICODONE ROSUVASTATIN\ROSUVASTATIN vs ROXITHROMYCIN ROSUVASTATIN\ROSUVASTATIN vs ROZANOLIXIZUMAB

Related Pages

ROSUVASTATIN\ROSUVASTATIN Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated ROSUVASTATIN\ROSUVASTATIN Demographics